MedPath

A clinical study of male Infertility in Covid 19 affected patients

Phase 3
Conditions
Health Condition 1: N469- Male infertility, unspecified
Registration Number
CTRI/2024/05/067118
Lead Sponsor
Faculty of Ayurveda Institute of Medical Sciences BH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Male patients aged 21 to 45 years Oligozoospermia (reduced sperm count) Multiple morphological abnormalities of sperm flagellum (MMAF) Previously diagnosed with COVID-19 infection along with male InfertilityKnown case of male Infertility without prior Covid 19 infection

Exclusion Criteria

Females Patients with evidence of malignancy Known patients of the mechanical physical cause of Infertility like antisperm antibodies condition Obstruction Surgical process etc Known cases of HIV AIDS Hepatitis Tuberculosis etc. Noncooperative Patients Previous surgery of the male reproductive tract Cryptorchidism Uses of exogenous testosterone Patients who have an addiction of alcohol smoking Patients who have completed participation in any other clinical trial during the past six (06) months Any other condition that the Principal Investigator thinks may jeopardize the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To asses the etiological factors in male infertility on Ayurvedic parametersTimepoint: 60 days
Secondary Outcome Measures
NameTimeMethod
Assessment of effect of Atmagupta churna in post covid & non-covid male infertility patientsTimepoint: 60 days
© Copyright 2025. All Rights Reserved by MedPath